IL114702A - Process for the production of biologically active transforming growth factor - Google Patents
Process for the production of biologically active transforming growth factorInfo
- Publication number
- IL114702A IL114702A IL11470295A IL11470295A IL114702A IL 114702 A IL114702 A IL 114702A IL 11470295 A IL11470295 A IL 11470295A IL 11470295 A IL11470295 A IL 11470295A IL 114702 A IL114702 A IL 114702A
- Authority
- IL
- Israel
- Prior art keywords
- growth factor
- biologically active
- transforming growth
- production
- active transforming
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94810439 | 1994-07-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL114702A0 IL114702A0 (en) | 1995-11-27 |
IL114702A true IL114702A (en) | 2005-03-20 |
Family
ID=8218293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11470295A IL114702A (en) | 1994-07-25 | 1995-07-24 | Process for the production of biologically active transforming growth factor |
Country Status (19)
Country | Link |
---|---|
US (1) | US7057016B2 (fi) |
EP (1) | EP0779896B1 (fi) |
JP (2) | JPH11505404A (fi) |
KR (1) | KR100394532B1 (fi) |
AT (1) | ATE207934T1 (fi) |
AU (1) | AU699879B2 (fi) |
CA (1) | CA2194578A1 (fi) |
DE (1) | DE69523611T2 (fi) |
DK (1) | DK0779896T3 (fi) |
ES (1) | ES2166402T3 (fi) |
FI (1) | FI118385B (fi) |
HU (1) | HU222829B1 (fi) |
IL (1) | IL114702A (fi) |
NO (1) | NO317730B1 (fi) |
NZ (1) | NZ290374A (fi) |
PT (1) | PT779896E (fi) |
TW (1) | TW517059B (fi) |
WO (1) | WO1996003433A1 (fi) |
ZA (1) | ZA956139B (fi) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4019432B2 (ja) * | 1995-12-21 | 2007-12-12 | 味の素株式会社 | ヒトアクチビンaのリフォールディング方法 |
DE10026713A1 (de) * | 2000-05-30 | 2001-12-06 | Walter Sebald | Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta |
US20030134292A1 (en) * | 2001-10-30 | 2003-07-17 | Farchaus Joseph W. | Thermostable DNA polymerases and methods of making same |
FR2871061B1 (fr) * | 2004-06-04 | 2007-08-10 | Coletica Sa | Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif |
US7572474B2 (en) | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
US8075934B2 (en) * | 2008-10-24 | 2011-12-13 | Mead Johnson Nutrition Company | Nutritional composition with improved digestibility |
WO2007033082A2 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (dmso) |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
AU2006291134C1 (en) | 2005-09-12 | 2013-08-15 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same |
US8480797B2 (en) | 2005-09-12 | 2013-07-09 | Abela Pharmaceuticals, Inc. | Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors |
GB0604966D0 (en) * | 2006-03-11 | 2006-04-19 | Renovo Ltd | Medicaments and proteins |
US8986769B2 (en) * | 2008-10-24 | 2015-03-24 | Mead Johnson Nutrition Company | Methods for preserving endogenous TGF-β |
BRPI0921494A2 (pt) | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
US9839609B2 (en) | 2009-10-30 | 2017-12-12 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis |
US10647777B2 (en) * | 2014-05-28 | 2020-05-12 | Genzyme Corporation | Methods of controlling the formation of disulfide bonds in protein solutions |
JP2016183118A (ja) * | 2015-03-25 | 2016-10-20 | 東ソー株式会社 | 増殖因子前駆体のリフォールディング方法 |
AU2017385096B2 (en) | 2016-12-30 | 2021-07-29 | Biogend Therapeutics Co., Ltd. | Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof |
CN118103390A (zh) * | 2021-10-11 | 2024-05-28 | 联邦高等教育系统匹兹堡大学 | 工程化TGF-β单体及其使用方法 |
GB2616476A (en) * | 2022-03-11 | 2023-09-13 | Multus Biotechnology Ltd | Recombinant transforming growth factor beta 3 in yeast |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0051985B2 (en) * | 1980-11-07 | 1989-12-27 | International Institute Of Cellular And Molecular Pathology (Icp) | Immunoassay of proteins |
GR79124B (fi) | 1982-12-22 | 1984-10-02 | Genentech Inc | |
US4620948A (en) | 1982-12-22 | 1986-11-04 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
EP0154434B1 (en) | 1984-02-17 | 1993-01-27 | Genentech, Inc. | Human transforming growth factor and precursor or fragment thereof, cells, dna, vectors and methods for their production, compositions and products containing them, and related antibodies and diagnostic methods |
US4572798A (en) | 1984-12-06 | 1986-02-25 | Cetus Corporation | Method for promoting disulfide bond formation in recombinant proteins |
US4731440A (en) | 1985-02-22 | 1988-03-15 | Monsanto Company | Method of somatotropin solubilization using dimethylsulfone and naturation |
IL78197A (en) | 1985-03-22 | 1991-07-18 | Genentech Inc | Nucleic acid encoding tgf-beta and its uses |
GB8508340D0 (en) | 1985-03-29 | 1985-05-09 | Creighton T E | Production of protein |
EP0208539A3 (en) | 1985-07-11 | 1988-08-03 | Repligen Corporation | Folding disulfide-cross-linkable proteins |
US5453363A (en) | 1985-10-23 | 1995-09-26 | Boehringer Mannheim Gmbh | Process for the activation of t-PA or Ing after genetic expression in prokaryotes |
JPH0759598B2 (ja) * | 1986-02-14 | 1995-06-28 | 藤沢薬品工業株式会社 | ヒトインスリン様成長因子▲i▼の製造法 |
NZ222168A (en) | 1986-10-20 | 1991-05-28 | Oncogene Science Inc | Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions |
AU612617B2 (en) | 1986-11-17 | 1991-07-18 | Sandoz Ag | Production and use of a novel t-cell suppressor factor |
FI100106B (fi) | 1986-12-05 | 1997-09-30 | Novartis Ag | Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi |
US4931548A (en) | 1987-01-30 | 1990-06-05 | Techne Corporation | Heterodimer form of transforming growth factor-beta |
IL86090A (en) | 1987-04-16 | 1993-03-15 | Cetus Oncology Corp | Production of purified, biologically active, bacterially produced recombinant human csf-1 |
JP2955294B2 (ja) | 1987-05-11 | 1999-10-04 | カイロン コーポレイション | 微生物から精製され、酸化され、再生された組換えインターロイキン‐2を回収する方法 |
US5162507A (en) | 1987-05-11 | 1992-11-10 | Cetus Corporation | Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
EP0293785A3 (en) * | 1987-05-29 | 1990-05-02 | Oncogen Limited Partnership | Cloning and expression of simian transforming growth factor-ss1 |
US4985544A (en) | 1987-08-04 | 1991-01-15 | Kyowa Hakko Kogyo Co., Ltd. | Process for renaturing fish growth hormone |
US5061786A (en) * | 1989-05-25 | 1991-10-29 | Genentech, Inc. | Biologically active polypeptides based on transforming growth factor-β |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
US5843463A (en) * | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
US5144006A (en) * | 1991-06-13 | 1992-09-01 | The Rockefeller University | Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides |
AU2738392A (en) * | 1991-11-11 | 1993-05-13 | Ciba-Geigy Ag | Novel hybrid transforming growth factors |
US5407810A (en) * | 1993-08-20 | 1995-04-18 | Genentech, Inc. | Aqueous multiple-phase isolation of polypeptide |
TW440566B (en) * | 1994-07-25 | 2001-06-16 | Novartis Ag | Novel process for the production of biologically active dimeric protein |
-
1995
- 1995-07-11 TW TW084107189A patent/TW517059B/zh not_active IP Right Cessation
- 1995-07-12 HU HU9700211A patent/HU222829B1/hu not_active IP Right Cessation
- 1995-07-12 AT AT95926858T patent/ATE207934T1/de not_active IP Right Cessation
- 1995-07-12 JP JP8505401A patent/JPH11505404A/ja not_active Withdrawn
- 1995-07-12 EP EP95926858A patent/EP0779896B1/en not_active Expired - Lifetime
- 1995-07-12 KR KR1019970700477A patent/KR100394532B1/ko not_active IP Right Cessation
- 1995-07-12 PT PT95926858T patent/PT779896E/pt unknown
- 1995-07-12 DK DK95926858T patent/DK0779896T3/da active
- 1995-07-12 AU AU31096/95A patent/AU699879B2/en not_active Ceased
- 1995-07-12 ES ES95926858T patent/ES2166402T3/es not_active Expired - Lifetime
- 1995-07-12 DE DE69523611T patent/DE69523611T2/de not_active Expired - Lifetime
- 1995-07-12 NZ NZ290374A patent/NZ290374A/en not_active IP Right Cessation
- 1995-07-12 CA CA002194578A patent/CA2194578A1/en not_active Abandoned
- 1995-07-12 WO PCT/EP1995/002719 patent/WO1996003433A1/en active IP Right Grant
- 1995-07-24 IL IL11470295A patent/IL114702A/xx not_active IP Right Cessation
- 1995-07-24 ZA ZA956139A patent/ZA956139B/xx unknown
-
1997
- 1997-01-22 FI FI970258A patent/FI118385B/fi active IP Right Grant
- 1997-01-24 NO NO19970326A patent/NO317730B1/no not_active IP Right Cessation
-
2001
- 2001-03-20 US US09/813,271 patent/US7057016B2/en not_active Expired - Fee Related
-
2006
- 2006-11-09 JP JP2006304238A patent/JP4354980B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO317730B1 (no) | 2004-12-13 |
JP2007082554A (ja) | 2007-04-05 |
US20020115834A1 (en) | 2002-08-22 |
AU699879B2 (en) | 1998-12-17 |
WO1996003433A1 (en) | 1996-02-08 |
ZA956139B (en) | 1996-03-07 |
DE69523611D1 (de) | 2001-12-06 |
EP0779896A1 (en) | 1997-06-25 |
JP4354980B2 (ja) | 2009-10-28 |
KR100394532B1 (ko) | 2003-10-22 |
FI118385B (fi) | 2007-10-31 |
DK0779896T3 (da) | 2002-02-18 |
PT779896E (pt) | 2002-03-28 |
NZ290374A (en) | 1998-07-28 |
IL114702A0 (en) | 1995-11-27 |
NO970326D0 (no) | 1997-01-24 |
NO970326L (no) | 1997-01-24 |
JPH11505404A (ja) | 1999-05-21 |
TW517059B (en) | 2003-01-11 |
US7057016B2 (en) | 2006-06-06 |
ES2166402T3 (es) | 2002-04-16 |
FI970258A (fi) | 1997-01-22 |
AU3109695A (en) | 1996-02-22 |
EP0779896B1 (en) | 2001-10-31 |
HU222829B1 (hu) | 2003-11-28 |
DE69523611T2 (de) | 2002-06-20 |
HUT76667A (en) | 1997-10-28 |
FI970258A0 (fi) | 1997-01-22 |
CA2194578A1 (en) | 1996-02-08 |
ATE207934T1 (de) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT76667A (en) | Process for the production of biologically active protein | |
IL114701A (en) | Process for the production of biologically active dimeric transforming growth factor | |
WO1998007745A3 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
CA2171699A1 (en) | Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell | |
ZA927993B (en) | A colostrum fraction, a process of preparing it and its use. | |
HU895836D0 (en) | Process for the preparation of carrier proteins | |
GB2302329B (en) | Yeast strains | |
EP0374044A3 (en) | Tgf - beta 1 / beta 2 : a novel chimeric transforming growth factor-beta. | |
EP0695801A3 (en) | Peptide compositions derived from yeast proteins, process for their preparation and their uses | |
ZA934037B (en) | Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same. | |
MX9700657A (es) | Nuevo proceso para la produccion de proteina biologicamente activa. | |
MX9700656A (es) | Proceso novedoso para la produccion de proteina dimerica biologicamente activa. | |
IL145403A0 (en) | Fragments of virus protein 2 or 3 of the polyoma virus, use for transporting active ingredients | |
ZA966371B (en) | The preparation of active peptides. | |
DK0454739T3 (da) | Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning | |
GB9613638D0 (en) | Protein gene product 9.5 purified to homogeneity, process for its preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |